Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Akebia Therapeutics (AKBA) Non-Current Deferred Tax Liability (2018 - 2020)

Historic Non-Current Deferred Tax Liability for Akebia Therapeutics (AKBA) over the last 3 years, with Q1 2020 value amounting to $35.1 million.

  • Akebia Therapeutics' Non-Current Deferred Tax Liability rose 80604.03% to $35.1 million in Q1 2020 from the same period last year, while for Mar 2020 it was $35.1 million, marking a year-over-year increase of 80604.03%. This contributed to the annual value of $109.4 million for FY2019, which is 842.15% down from last year.
  • According to the latest figures from Q1 2020, Akebia Therapeutics' Non-Current Deferred Tax Liability is $35.1 million, which was up 80604.03% from $109.4 million recorded in Q4 2019.
  • Akebia Therapeutics' 5-year Non-Current Deferred Tax Liability high stood at $119.4 million for Q4 2018, and its period low was $1.8 million during Q3 2019.
  • Over the past 3 years, Akebia Therapeutics' median Non-Current Deferred Tax Liability value was $19.5 million (recorded in 2019), while the average stood at $45.4 million.
  • In the last 5 years, Akebia Therapeutics' Non-Current Deferred Tax Liability plummeted by 842.15% in 2019 and then surged by 80604.03% in 2020.
  • Over the past 3 years, Akebia Therapeutics' Non-Current Deferred Tax Liability (Quarter) stood at $119.4 million in 2018, then decreased by 8.42% to $109.4 million in 2019, then crashed by 67.9% to $35.1 million in 2020.
  • Its last three reported values are $35.1 million in Q1 2020, $109.4 million for Q4 2019, and $1.8 million during Q3 2019.